Bianchi BR - Search Results

1

Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.

Lin CW, Miller TR, Witte DG, Bianchi BR, Stashko M, Manelli AM, Frail DE. Lin CW, et al. Among authors: bianchi br. Mol Pharmacol. 1995 Jan;47(1):131-9. Mol Pharmacol. 1995. PMID: 7838121

2

ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.

Shiosaki K, Jenner P, Asin KE, Britton DR, Lin CW, Michaelides M, Smith L, Bianchi B, Didomenico S, Hodges L, Hong Y, Mahan L, Mikusa J, Miller T, Nikkel A, Stashko M, Witte D, Williams M. Shiosaki K, et al. J Pharmacol Exp Ther. 1996 Jan;276(1):150-60. J Pharmacol Exp Ther. 1996. PMID: 8558425

3

Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.

Lin CW, Shiosaki K, Miller TR, Witte DG, Bianchi BR, Wolfram CA, Kopecka H, Craig R, Wagenaar F, Nadzan AM. Lin CW, et al. Among authors: bianchi br. Mol Pharmacol. 1991 Mar;39(3):346-51. Mol Pharmacol. 1991. PMID: 1706470

4

Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.

Lin CW, Bianchi BR, Miller TR, Stashko MA, Wang SS, Curzon P, Bednarz L, Asin KE, Britton DR. Lin CW, et al. Among authors: bianchi br. J Pharmacol Exp Ther. 1996 Mar;276(3):1022-9. J Pharmacol Exp Ther. 1996. PMID: 8786531

5

Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues.

Shiosaki K, Lin CW, Kopecka H, Craig RA, Bianchi BR, Miller TR, Witte DG, Stashko M, Nadzan AM. Shiosaki K, et al. Among authors: bianchi br. J Med Chem. 1992 May 29;35(11):2007-14. doi: 10.1021/jm00089a010. J Med Chem. 1992. PMID: 1375964

6

Both CCK-A and CCK-B/gastrin receptors mediate pepsinogen release in guinea pig gastric glands.

Lin CW, Bianchi BR, Miller TR, Witte DG, Wolfram CA. Lin CW, et al. Among authors: bianchi br. Am J Physiol. 1992 Jun;262(6 Pt 1):G1113-20. doi: 10.1152/ajpgi.1992.262.6.G1113. Am J Physiol. 1992. PMID: 1616041

7

Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-a receptor agonists.

Shiosaki K, Lin CW, Kopecka H, Tufano MD, Bianchi BR, Miller TR, Witte DG, Nadzan AM. Shiosaki K, et al. Among authors: bianchi br. J Med Chem. 1991 Sep;34(9):2837-42. doi: 10.1021/jm00113a023. J Med Chem. 1991. PMID: 1716682

8

A71378: a CCK agonist with high potency and selectivity for CCK-A receptors.

Lin CW, Holladay MW, Witte DG, Miller TR, Wolfram CA, Bianchi BR, Bennett MJ, Nadzan AM. Lin CW, et al. Among authors: bianchi br. Am J Physiol. 1990 Apr;258(4 Pt 1):G648-51. doi: 10.1152/ajpgi.1990.258.4.G648. Am J Physiol. 1990. PMID: 2333977

9

Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species.

Bianchi BR, Miller TR, Witte DG, Lin CW. Bianchi BR, et al. J Pharmacol Exp Ther. 1994 Feb;268(2):996-1002. J Pharmacol Exp Ther. 1994. PMID: 7509394

10

Novel Asp32-replacement tetrapeptide analogues as potent and selective CCK-A agonists.

Elliott RL, Kopecka H, Tufano MD, Shue YK, Gauri AJ, Lin CW, Bianchi BR, Miller TR, Witte DG, Stashko MA, et al. Elliott RL, et al. Among authors: bianchi br. J Med Chem. 1994 May 27;37(11):1562-8. doi: 10.1021/jm00037a005. J Med Chem. 1994. PMID: 8201590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters